Search results
Results from the WOW.Com Content Network
Armodafinil, sold under the brand name Nuvigil, is a wakefulness-promoting medication which is used to treat excessive daytime sleepiness associated with obstructive sleep apnea, narcolepsy, and shift work disorder. [1] It is also used off-label for certain other indications. [10] The drug is taken by mouth. [1]
Solriamfetol is used to promote wakefulness in the treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea in adults. [1] It appears to be more effective in improving excessive daytime sleepiness associated with obstructive sleep apnea than certain other wakefulness-promoting agents including modafinil, armodafinil, and pitolisant.
Since 2020, Duearity has been developing the world's smallest and most flexible tinnitus aid that emits white noise through bone conduction technology. [ 29 ] [ 30 ] It is a patented medtech CE class IIa product [ 31 ] [ 32 ] with FDA 510(k) clearance in the U.S. [ 33 ] [ 34 ] It is a non-invasive device that attaches behind the ears and keeps ...
A review bomb is a malicious Internet phenomenon in which a large number of people or a few people with multiple accounts [1] post negative user reviews online in an attempt to harm the sales or popularity of a product, a service, or a business. [2]
In February 2022, Teva agreed to a $225 million settlement with the state of Texas to end claims that it fueled an opioid epidemic in the state by improperly marketing pain medicine. [ 115 ] In August 2023, Teva admitted to price-fixing charges related to the generic cholesterol drug Pravastatin , and agreed to pay a $225 million fine, after a ...
LOS ANGELES (AP) - Southern California doctors were bribed to prescribe a pain-relief concoction as part of a $25 million workers' compensation scam that inadvertently caused a baby's death ...
The annoyance of tinnitus also tends to decline over time. In some people, tinnitus spontaneously disappears. [1] A Cochrane review found only one sufficiently rigorous study of TRT and noted that while the study suggested benefit in the treatment of tinnitus, the study quality was not good enough to draw firm conclusions. [5]
The pharmaceutical company Cephalon, the original United States market rights holder of modafinil, has demonstrated initiative in the development of a successor to the prototypical eugeroic. [25]